Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.440 +0.070 (+2.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
2 Cathie Wood Stocks That Could Be Hidden Gems ↗
These two biotech stocks could deliver life-altering returns for long-term investors. 
Via The Motley Fool
News headline image
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought ↗
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
News headline image
Prime Medicine to Present at Investor Conferences in June
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
News headline image
Prime Medicine to Present at Virtual Investor Conferences in May
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗
 
Via Benzinga
News headline image
Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share. 
Via Benzinga
News headline image
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. 
Via Benzinga
News headline image
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Opening Day: Snail Slides In Public Debut, Then Announces Share Buyback ↗
Shares of digital gaming company Snail opened for trading more than 50% lower at $2.20 after pricing shares of its Class A common stock at $5, then followed its first day on the market with a buyback... 
Via Talk Markets
News headline image
$41 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying ↗
Although US stocks closed mostly lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Prime Medicine Announces Closing of Upsized Initial Public Offering
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Stock Down 18.98% Since IPO ↗
Prime Medicine (NASDAQ:PRME) opened up its shares for public trading for the first time since it filed for IPO in September 2022. The company agreed to initially offer 10.29 million shares to the... 
Via Benzinga
News headline image
What Is Going on With Silo Pharma (SILO) Stock Today? ↗
Silo Pharma (SILO) stock is falling on Thursday despite the company releasing positive data from a pre-clinical Alzheimer's study. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.